Records containing: Hypercholesterolemia

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2012-10-12
  Retrospective Analysis on the Risk of Cardiovascular (CV) Events in HIV- Infected Subjects From Latin America Treated With a Lopinavir/Ritonavir (LPV/r) Based HAART Regimen vs. an Efavirenz (EFV) Based HAART Regimen
• CLINICAL_TRIALS study record update · 2012-10-12
  The RITA-study -- An Open Study to Evaluate the Blood Lipid Lowering Effect of Rosuvastatin Versus Fluvastatin and the Bilateral Interaction Between Everolimus and Rosuvastatin in Renal Transplant Recipients
• CLINICAL_TRIALS study record update · 2012-10-05
  Intensive Glycemic Control and Skeletal Health Study - Ancillary Study to the Action to Control Cardiovascular Risk in Diabetes Trial (ACCORD-BONE)
• CLINICAL_TRIALS study record update · 2012-08-01
  A 12-week, Multicenter, Randomized, Double-Blind, Parallel-Group Study of the Combination of ABT-335 and Rosuvastatin Compared to ABT-335 and Rosuvastatin Monotherapy in Subjects With Type IIa and IIb Dyslipidemia
• CLINICAL_TRIALS study record update · 2012-07-02
  Efficacy of a Microencapsulated Probiotic Yogurt Formulation as a Health Promoting Agent
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-06-21
  Effect of Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) on Metabolic Syndrome
• CLINICAL_TRIALS study record update · 2012-06-19
  The Effect of Ezetimibe 10 mg, Simvastatin 20 mg and the Combination of Simvastatin 20 mg Plus 10 mg Ezetimibe on Low Density Lipoprotein (LDL)-Subfractions in Patients With Type 2 Diabetes
• CLINICAL_TRIALS study record update · 2012-06-14
  ClinicalTrials.gov study NCT00548145
• CLINICAL_TRIALS study record update · 2012-06-14
  Evaluation of a Primary Treatment Algorithm Using Combination Therapy for the Management of Patients With Hypertension and Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-06-07
  A Randomized, Controlled Parallel Study to Evaluate the Effects of a Non-Commercial Soy Protein Product on Fecal Bile Acids and Blood Lipids in Men and Women With Mild to Moderate Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-05-28
  Statin Therapeutic Interchange by Pharmacist Collaborative Practice Process
• CLINICAL_TRIALS study record update · 2012-05-24
  A Double-blind, Randomized Placebo-controlled Study to Evaluate the Efficacy and Safety of TAK-475 50 mg, 100 mg, or Placebo When Co-administered With Atorvastatin (10 mg to 40 mg) in Subjects With Primary Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-05-24
  A Double-Blind, Randomized, Placebo-Controlled Factorial Study to Evaluate the Efficacy and Safety of Lapaquistat and Simvastatin Alone and in Combination in Subjects With Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-05-24
  A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 (100 mg) Vs Placebo When Coadministered With Atorvastatin (10 or 20 mg) in Subjects With Primary Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-05-24
  A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 100 mg in the Morning vs Lapaquistat Acetate 100 mg in the Evening vs Lapaquistat Acetate 50 mg Twice Daily vs Placebo in Subjects With Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-05-24
  A Double-Blind, Double-Dummy, Randomized, Parallel Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 100 mg and Lapaquistat Acetate 100 mg Administered in Combination With Ezetimibe 10 mg vs Ezetimibe 10 mg in Subjects With Primary Dyslipidemia
• CLINICAL_TRIALS study record update · 2012-05-24
  A Double-blind, Placebo-controlled, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 or Placebo When Co-administered With Current Lipid-lowering Therapy in Subjects With Homozygous Familial Hypercholesterolemia.
• CLINICAL_TRIALS study record update · 2012-05-24
  A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg vs Placebo in Subjects With Hypercholesterolemia, With an Optional Open-Label Extension
• CLINICAL_TRIALS study record update · 2012-05-24
  A Placebo-controlled, Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 50 mg and 100 mg Versus Placebo, When Co-administered With Simvastatin 20 mg or 40 mg in Subjects With Primary Dyslipidemia.
• CLINICAL_TRIALS study record update · 2012-05-24
  A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 50 mg, 100 mg or Placebo When Coadministered With Rosuvastatin 10 mg or 20 mg in Subjects With Primary Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-05-24
  Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-05-24
  An Open-Label Extension Study to Evaluate the Safety and Tolerability of Lapaquistat Acetate in Subjects With Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-05-24
  A Double-Blind, Randomized Study to Evaluate the Efficacy and Safety of Lapaquistat or Placebo When Co-Administered With High Dose Statin Therapy in Subjects With Primary Hypercholesterolemia
• CLINICAL_TRIALS study record update · 2012-05-15
  Practice-based Opportunities for Weight Reduction Trial at University of Pennsylvania
• CLINICAL_TRIALS study record update · 2012-05-09
  Outpatient Strategy of Primary Prevention of Cardiovascular Diseases in Childhood and Adolescence: the Role of Physical Activity